If a primary tumor is ERα-positive, more than 80% of the lymph node metastasis retains ERα [163], although gene expression profiling and immunohistochemical analyses have shown the differential regulation of genes by estradiol in tumors and matched lymph node metastasis [164]. This evidence concerns the gene ESR1 and metastatic malignant neoplasm in the lymph nodes.